- Report
- December 2020
- 60 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Drug Pipelines
- December 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- August 2022
- 87 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- December 2020
- 60 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Report
- March 2023
- 114 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- April 2023
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- June 2020
- 113 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- June 2020
- 114 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- March 2018
- 120 Pages
Global
From €4085EUR$4,250USD£3,503GBP
- Report
- August 2022
- 175 Pages
Global
From €9131EUR$9,500USD£7,830GBP
- Report
- August 2021
- 77 Pages
India
From €3364EUR$3,500USD£2,885GBP
- Report
- August 2022
- 116 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- August 2022
- 120 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- January 2022
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- July 2021
- 50 Pages
China
From €2499EUR$2,600USD£2,143GBP
- Report
- February 2023
- 178 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- November 2020
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- November 2020
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- March 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more